⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Levi & Korsinsky Investigating Whether Alvotech (ALVO) Misled Investors - Securities Law Violations Possible
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
accessnewswire.com
ALVO
Securities Investigation: Levi & Korsinsky Investigates Alvotech (ALVO) on Behalf of Investors
accessnewswire.com
ALVO
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Shareholders to Inquire about Securities Investigation
accessnewswire.com
ALVO
Levi & Korsinsky Launches Fraud Investigation on Behalf of Alvotech (ALVO) Shareholders
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
prnewswire.com
ALVO
ATTENTION ALVO Investors: Securities Fraud Investigation Underway – Contact Levi & Korsinsky
accessnewswire.com
ALVO
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
globenewswire.com
ALVO
Alvotech og Advanz Pharma fá markaðsleyfi á Evrópska efnahagssvæðinu fyrir Gobivaz, fyrstu hliðstæðuna við Simponi
globenewswire.com
ALVO